Woebot

Woebot, an AI-driven CBT chatbot from Stanford psychologists, boasts FDA Breakthrough Device designation and clinical trials showing a 22% reduction in depression symptoms within two weeks, a hard data point that sets it apart. Woebot's clinical credentials are unmatched among free tools, though its lack of human support limits it to mild-to-moderate cases.